全文获取类型
收费全文 | 698篇 |
免费 | 28篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 6篇 |
妇产科学 | 1篇 |
基础医学 | 164篇 |
口腔科学 | 11篇 |
临床医学 | 32篇 |
内科学 | 80篇 |
皮肤病学 | 7篇 |
神经病学 | 160篇 |
特种医学 | 4篇 |
外科学 | 21篇 |
综合类 | 67篇 |
预防医学 | 8篇 |
眼科学 | 8篇 |
药学 | 82篇 |
中国医学 | 62篇 |
肿瘤学 | 14篇 |
出版年
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 5篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 12篇 |
2017年 | 9篇 |
2016年 | 9篇 |
2015年 | 6篇 |
2014年 | 23篇 |
2013年 | 27篇 |
2012年 | 32篇 |
2011年 | 36篇 |
2010年 | 29篇 |
2009年 | 32篇 |
2008年 | 26篇 |
2007年 | 29篇 |
2006年 | 24篇 |
2005年 | 28篇 |
2004年 | 21篇 |
2003年 | 25篇 |
2002年 | 26篇 |
2001年 | 16篇 |
2000年 | 11篇 |
1999年 | 19篇 |
1998年 | 16篇 |
1997年 | 15篇 |
1996年 | 14篇 |
1995年 | 12篇 |
1994年 | 20篇 |
1993年 | 16篇 |
1992年 | 9篇 |
1991年 | 7篇 |
1990年 | 8篇 |
1989年 | 11篇 |
1988年 | 8篇 |
1987年 | 5篇 |
1986年 | 11篇 |
1985年 | 24篇 |
1984年 | 20篇 |
1983年 | 19篇 |
1982年 | 12篇 |
1981年 | 14篇 |
1980年 | 12篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有729条查询结果,搜索用时 15 毫秒
1.
目的探讨当归龙荟片联合普芦卡必利治疗慢性功能性便秘的临床疗效。方法选取2018年5月-2019年5月在北京市肛肠医院治疗的慢性功能性便秘患者122例,根据用药的差别分为对照组(61例)和治疗组(61例)。对照组口服琥珀酸普芦卡必利片,2mg/次,1次/d;治疗组在对照组基础上口服当归龙荟片,4片/次,2次/d。两组患者均经4周治疗。观察两组患者临床疗效,同时比较治疗前后两组患者临床症状评分、PAC-QOL积分、结肠传输试验积分、Bristol和SF-36评分,及血清5-羟色胺(5-HT)、血管活性肠肽(VIP)、P物质(SP)和一氧化氮(NO)水平。结果治疗后,对照组和治疗组临床有效率分别为80.33%和96.72%,两组比较差异具有统计学意义(P<0.05)。经治疗,两组症状积分均明显降低(P<0.05),且治疗组比对照组降低更明显(P<0.05)。经治疗,两组患者PAC-QOL积分和结肠传输试验积分明显降低(P<0.05),而Bristol和SF-36评分明显升高(P<0.05),且治疗组患者明显好于对照组(P<0.05)。经治疗,两组患者血清SP、5-HT水平均显著升高(P<0.05),而VIP和NO水平均明显降低(P<0.05),且治疗组患者SP、5-HT、VIP和NO水平明显优于对照组(P<0.05)。结论当归龙荟片联合普芦卡必利治疗慢性功能性便秘可有效改善患者临床症状,促进患者生活质量改善,具有一定的临床推广应用价值。 相似文献
2.
M. Urpi-Sarda E. Almanza-Aguilera R. Llorach R. Vázquez-Fresno R. Estruch D. Corella J.V. Sorli F. Carmona A. Sanchez-Pla J. Salas-Salvadó C. Andres-Lacueva 《Diabetes & metabolism》2019,45(2):167-174
Aim
To characterize the urinary metabolomic fingerprint and multi-metabolite signature associated with type 2 diabetes (T2D), and to classify the population into metabotypes related to T2D.Methods
A metabolomics analysis using the 1H-NMR-based, non-targeted metabolomic approach was conducted to determine the urinary metabolomic fingerprint of T2D compared with non-T2D participants in the PREDIMED trial. The discriminant metabolite fingerprint was subjected to logistic regression analysis and ROC analyses to establish and to assess the multi-metabolite signature of T2D prevalence, respectively. Metabotypes associated with T2D were identified using the k-means algorithm.Results
A total of 33 metabolites were significantly different (P < 0.05) between T2D and non-T2D participants. The multi-metabolite signature of T2D comprised high levels of methylsuccinate, alanine, dimethylglycine and guanidoacetate, and reduced levels of glutamine, methylguanidine, 3-hydroxymandelate and hippurate, and had a 96.4% AUC, which was higher than the metabolites on their own and glucose. Amino-acid and carbohydrate metabolism were the main metabolic alterations in T2D, and various metabotypes were identified in the studied population. Among T2D participants, those with a metabotype of higher levels of phenylalanine, phenylacetylglutamine, p-cresol and acetoacetate had significantly higher levels of plasma glucose.Conclusion
The multi-metabolite signature of T2D highlights the altered metabolic fingerprint associated mainly with amino-acid, carbohydrate and microbiota metabolism. Metabotypes identified in this patient population could be related to higher risk of long-term cardiovascular events and therefore require further studies. Metabolomics is a useful tool for elucidating the metabolic complexity and interindividual variation in T2D towards the development of stratified precision nutrition and medicine.Trial registration at www.controlled-trials.com: ISRCTN35739639. 相似文献3.
目的:研究益气开秘方联合伊托必利及乳果糖对气阴两虚型便秘患者疗效及血清5-羟色胺(5-HT)、胃动素(MOT)、血管活性肠肽(VIP)水平的影响。方法:选择气阴两虚型便秘患者168例。依据随机数字表法将其分成观察组和对照组各84例,对照组应用伊托必利和乳果糖。观察组加用益气开秘方。两组均治疗4周,对比两组疗效,临床症状评分,血清5-HT、MOT及VIP水平及并发症。结果:观察组总有效率97.62%,较对照组89.29%明显更高(P<0.05)。治疗后两组临床症状评分均明显低于治疗前,且观察组较对照组明显降低(P<0.05)。治疗后两组血清5-HT及VIP水平均明显低于治疗前,且观察组较对照组明显降低(P<0.05); 治疗后两组血清MOT水平明显高于治疗前,且观察组较对照组明显升高(P<0.05)。观察组并发症总发生率3.57%较对照组11.90%明显更低(P<0.05)。结论:应用益气开秘方联合伊托必利及乳果糖对气阴两虚型便秘患者的疗效较好,安全性较高,并可改善患者的血清5-HT、MOT及VIP水平。 相似文献
4.
目的 研究复方阿嗪米特肠溶片联合多酶片治疗功能性消化不良的效果。方法 选择2016年1月—2018年12月泰州市第三人民医院收治的60例功能性消化不良患者,随机分为两组,每组各30例。对照组患者口服多酶片,3片/次,3次/d。观察组在对照组的基础上加服复方阿嗪米特肠溶片,10 mg/次,3次/d。两组患者均治疗1个月。比较两组的临床治疗效果,症状改善情况和胃肠激素水平。结果 治疗后,观察组的有效率为93.33%,明显高于对照组的70.00%(P<0.05)。治疗后,两组餐后饱胀、嗳气、上腹痛以及上腹部烧灼感评分均明显降低(P<0.05),且观察组症状评分明显更低(P<0.05)。治疗后,两组的胃动素(MTL)和神经肽Y(NPY)水平明显升高,血管活性肽(VIP)水平均明显降低(P<0.05),且观察组胃肠激素水平明显优于对照组(P<0.05)。两组腹胀、腹泻、呕吐和头晕的发生率无明显的差异(P>0.05)。结论 复方阿嗪米特肠溶片联合多酶片能更为显著地改善功能性消化不良的症状,提高疗效,调节胃肠激素水平。 相似文献
5.
Yongjun He Hua Yang Tingting Geng Tian Feng Dongya Yuan Longli Kang Manling Luo Tianbo Jin 《International journal of clinical and experimental pathology》2015,8(10):13293-13303
Background: It is well-established that differences among ethnic groups in drug responses are primarily due to the genetic diversity of pharmacogenes. A number of genes or variants that play a crucial role in drug responses have been designated Very Important Pharmacogenes (VIP) by the PharmGKB database. Clarifying the polymorphic distribution of VIPs in different ethnic groups will aid in personalized medicine for specific populations. Methods: We sequenced 85 VIP variants in the Lhoba population based on the PharmGKB database. The polymorphic distribution of the 85 VIP variants in 100 Lhoba subjects was determined and compared with that of 11 major HapMap populations, including ASW, CEU, CHB, CHD, GIH, JPT, LWK, MEX, MKK, TSI, and YRI. We used χ2 tests to identify significantly different loci between these populations. We downloaded SNP allele frequencies from the ALlele FREquency Database to observe the global genetic variation distribution for these specific loci. And then we used Structure software to perform the genetic structure analysis of 12 populations. Results: Based on comparisons of selected available loci, we found that 23, 28, 16, 10, 20, 16, 24, 19, 22, 21 and 36 of the selected VIP variant genotype frequencies in the Lhoba population differed from those of the ASW, CEU, CHB, CHD, GIH, JPT, LWK, MEX, MKK, TSI, and YRI populations, respectively. In addition, Pairwise FST values and clustering analyses also showed the VIP variants in Lhoba exhibited a close genetic affinity with CHD, CHB and JPT populations. Conclusion: Our results complement pharmacogenomic data on the Lhoba ethnic group and may be helpful in the diagnosis of certain diseases in minorities. 相似文献
6.
Thomas Bakken Seong Wook Kang Sunantha Kosonsiriluk Takehito Kuwayama Yupaporn Chaiseha Mohamed E. El Halawani 《Acta histochemica》2014
In the turkey, exogenous serotonin (5-hydroxytryptamine, 5-HT) increases prolactin (PRL) secretion by acting through the dopaminergic (DAergic) system. In the present study, infusion of the 5-HT2C receptor agonist, (R)(−)-DOI hydrochloride (DOI), into the third ventricle stimulates PRL secretion, whereas the 5-HT1A receptor agonist, (+/−)-8-OH-DPAT hydrobromide (DPAT), inhibits PRL secretion. Using the immediate-early gene, c-fos, as an indicator of neuronal activity, in situ hybridization histochemistry showed preferential c-fos co-localization within tyrosine hydroxylase immunoreactive neurons (the rate limiting enzyme in DA synthesis) in the areas of the nucleus preopticus medialis (POM) and the nucleus premammillaris (PMM), in response to DPAT and DOI, respectively. To clarify the involvement of 5-HT1A and 5-HT2C receptors in PRL regulation, their mRNA expression was determined on hypothalamic tissue sections from birds in different reproductive stages. A significant difference in 5-HT1A receptor was observed, with the POM of hypoprolactinemic short day and photorefractory birds showing the highest expression. 5-HT2C receptors mRNA did not change during the reproductive cycle. The data presented support the notion that DA neurons in the PMM and POM mediate the stimulatory and inhibitory effects of 5-HT, respectively, on PRL secretion and the 5-HTergic system can both stimulate and inhibit PRL secretion. 相似文献
7.
Virtually every eukaryotic cell has an endogenous circadian clock and a biological sex. These cell-based clocks have been conceptualized as oscillators whose phase can be reset by internal signals such as hormones, and external cues such as light. The present review highlights the inter-relationship between circadian clocks and sex differences. In mammals, the suprachiasmatic nucleus (SCN) serves as a master clock synchronizing the phase of clocks throughout the body. Gonadal steroid receptors are expressed in almost every site that receives direct SCN input. Here we review sex differences in the circadian timing system in the hypothalamic–pituitary–gonadal axis (HPG), the hypothalamic–adrenal–pituitary (HPA) axis, and sleep–arousal systems. We also point to ways in which disruption of circadian rhythms within these systems differs in the sexes and is associated with dysfunction and disease. Understanding sex differentiated circadian timing systems can lead to improved treatment strategies for these conditions. 相似文献
8.
9.
目的:观察基于"脑-肠轴"学说组方的清开通灌肠液,对内毒素性发热兔的退热效应及VIP、IL-2在发热中的变化。方法:日本大耳白家兔60只,随机分成4组:正常组、模型组、清开灵组和清开通组。模型组、清开灵组及清开通组,各组经耳缘静脉注射无热源生理盐水稀释的内毒素,建立兔内毒素性发热模型。同时清开灵组、清开通组分别予以清开灵、清开通灌肠液灌肠。注射内毒素2h后,清开灵组、清开通组再予灌肠1次。4h后,各组动物随机抽取10只,采集脑、肠及外周血标本,用放射免疫法检测脑、肠及血浆中VIP、IL-2含量。持续观察每组另外5只动物体温变化情况,每间隔10min记录1次体温,连续测温12h。结果:清开灵组和清开通组动物的体温与模型组相比都有明显降低(P0.01),但清开通组降低比清开灵组更为显著(P0.05)。脑肠及血浆中VIP和IL-2的含量都显著低于模型组(P0.01),尤其清开通组较清开灵组降低幅度更大,二者有显著差异(P0.05)。结论:"清开"与"通腑"合治,较单一清开法在退热及提高机体免疫方面效果更著,VIP和IL-2在发热中起正调节作用。 相似文献